APA (7th ed.) Citation

NB, M., X, C., L, M., CC, H., R, N., D, L., & S, G. (2021). Single- and Multiple-Dose Pharmacokinetics and Pharmacodynamics of PN-943, a Gastrointestinal-Restricted Oral Peptide Antagonist of α4β7, in Healthy Volunteers. Clinical pharmacology in drug development, 10(11), 1263. https://doi.org/10.1002/cpdd.946

Chicago Style (17th ed.) Citation

NB, Modi, Cheng X, Mattheakis L, Hwang CC, Nawabi R, Liu D, and Gupta S. "Single- and Multiple-Dose Pharmacokinetics and Pharmacodynamics of PN-943, a Gastrointestinal-Restricted Oral Peptide Antagonist of α4β7, in Healthy Volunteers." Clinical Pharmacology in Drug Development 10, no. 11 (2021): 1263. https://doi.org/10.1002/cpdd.946.

MLA (9th ed.) Citation

NB, Modi, et al. "Single- and Multiple-Dose Pharmacokinetics and Pharmacodynamics of PN-943, a Gastrointestinal-Restricted Oral Peptide Antagonist of α4β7, in Healthy Volunteers." Clinical Pharmacology in Drug Development, vol. 10, no. 11, 2021, p. 1263, https://doi.org/10.1002/cpdd.946.